Grown Rogue International (GRUSF) Net Cash Flow Growth (3y) (2014 - 2023)
Grown Rogue International (GRUSF) Net Cash Flow Growth (3y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -49.94% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -62.71% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 60.82% |
| Apr 30, 2023 | -37.15% |
| Jan 31, 2023 | 82.36% |
| Jan 31, 2022 | 56.90% |
| Oct 31, 2021 | 7,801.48% |
| Jul 31, 2021 | -144.41% |
| Apr 30, 2021 | 99.81% |
| Jan 31, 2021 | 5.26% |
| Aug 31, 2018 | 32.96% |
| May 31, 2018 | 60.68% |
| May 31, 2017 | -74.75% |
| Nov 30, 2016 | -35.23% |
| Aug 31, 2016 | 35.89% |
| Nov 30, 2014 | 31.13% |